Pacific Radiance Ltd.'s (SGX:RXS) solid earnings report last week was underwhelming to investors. We think that they may be worried about something else, so we did some analysis and found that investors have noticed some soft numbers underlying the profit.
See our latest analysis for Pacific Radiance
SGX:RXS Earnings and Revenue History November 21st 2022
Examining Cashflow Against Pacific Radiance's Earnings
As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. This ratio tells us how much of a company's profit is not backed by free cashflow.
That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.
Over the twelve months to September 2022, Pacific Radiance recorded an accrual ratio of 4.22. Ergo, its free cash flow is significantly weaker than its profit. As a general rule, that bodes poorly for future profitability. In fact, it had free cash flow of US$4.3m in the last year, which was a lot less than its statutory profit of US$330.3m. Pacific Radiance shareholders will no doubt be hoping that its free cash flow bounces back next year, since it was down over the last twelve months. Unfortunately for shareholders, the company has also been issuing new shares, diluting their share of future earnings. The good news for shareholders is that Pacific Radiance's accrual ratio was much better last year, so this year's poor reading might simply be a case of a short term mismatch between profit and FCF. Shareholders should look for improved cashflow relative to profit in the current year, if that is indeed the case.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Pacific Radiance.
In order to understand the potential for per share returns, it is essential to consider how much a company is diluting shareholders. In fact, Pacific Radiance increased the number of shares on issue by 530% over the last twelve months by issuing new shares. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. Check out Pacific Radiance's historical EPS growth by clicking on this link.
A Look At The Impact Of Pacific Radiance's Dilution On Its Earnings Per Share (EPS)
Pacific Radiance was losing money three years ago. The good news is that profit was up 3,274% in the last twelve months. But EPS was less impressive, up only 2,109% in that time. So you can see that the dilution has had a fairly significant impact on shareholders.
In the long term, earnings per share growth should beget share price growth. So it will certainly be a positive for shareholders if Pacific Radiance can grow EPS persistently. However, if its profit increases while its earnings per share stay flat (or even fall) then shareholders might not see much benefit. For that reason, you could say that EPS is more important that net income in the long run, assuming the goal is to assess whether a company's share price might grow.
Our Take On Pacific Radiance's Profit Performance
As it turns out, Pacific Radiance couldn't match its profit with cashflow and its dilution means that earnings per share growth is lagging net income growth. On reflection, the above-mentioned factors give us the strong impression that Pacific Radiance'sunderlying earnings power is not as good as it might seem, based on the statutory profit numbers. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Be aware that Pacific Radiance is showing 3 warning signs in our investment analysis and 2 of those shouldn't be ignored...
In this article we've looked at a number of factors that can impair the utility of profit numbers, and we've come away cautious. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
太平洋輻射有限公司的(SGX:RXS)上週穩健的收益報告對投資者來説並不令人印象深刻。我們認為他們可能在擔心其他事情,所以我們做了一些分析,發現投資者注意到了利潤背後的一些疲軟數據。
查看我們對太平洋輻射度的最新分析
新交所:RXS收益和收入歷史2022年11月21日
審查現金流與太平洋輻射公司的收益
正如金融書呆子們已經知道的那樣,現金流應計比率是評估一家公司的自由現金流(FCF)與利潤匹配程度的關鍵指標。簡單地説,這個比率是從淨利潤中減去FCF,然後用這個數字除以該公司在此期間的平均運營資產。這個比率告訴我們,一家公司的利潤中有多少不是由自由現金流支持的。
這意味着負的應計比率是一件好事,因為它表明該公司帶來的自由現金流比其利潤所暗示的要多。雖然應計比率高於零並不令人擔憂,但我們確實認為,當一家公司的應計比率相對較高時,這一點值得注意。這是因為一些學術研究表明,高應計制比率往往會導致較低的利潤或較低的利潤增長。
在截至2022年9月的12個月內,太平洋輻射錄得4.22的應計比率。因此,其自由現金流明顯弱於其利潤。一般來説,這對未來的盈利能力來説是個不好的預兆。事實上,該公司去年的自由現金流為430萬美元,遠低於其3.303億美元的法定利潤。Pacific Radiance的股東無疑希望其自由現金流在明年反彈,因為它在過去12個月裏一直在下降。對股東來説,不幸的是,該公司也一直在發行新股,稀釋了他們在未來收益中的份額。對股東來説,好消息是Pacific Radiance去年的應計比率要好得多,因此今年的糟糕讀數可能只是利潤和FCF之間短期錯配的一個例子。如果情況確實如此,股東應該期待本年度相對於利潤的現金流有所改善。
注:我們總是建議投資者檢查資產負債表的實力。點擊此處查看我們對太平洋輻射的資產負債表分析。
為了理解每股回報的潛力,考慮一家公司稀釋股東的程度是至關重要的。事實上,Pacific Radiance通過發行新股,在過去12個月中將發行的股票數量增加了530%。這意味着它的收益被分配到更多的股票中。每股收益等指標幫助我們瞭解實際股東從公司利潤中受益的程度,而淨收益水平則讓我們更好地瞭解公司的絕對規模。點擊此鏈接,查看Pacific Radiance的歷史每股收益增長情況。
太平洋輻射稀釋對其每股收益(EPS)的影響
太平洋輻射三年前處於虧損狀態。好消息是,在過去的12個月裏,利潤增長了3274%。但每股收益沒有那麼令人印象深刻,在此期間僅上漲了2109%。因此,你可以看到,股權稀釋對股東產生了相當大的影響。
從長遠來看,收益每股經濟增長應該會帶動股價上漲。因此,如果Pacific Radiance能夠持續增長每股收益,對股東來説肯定是一個利好。然而,如果其利潤增加,而每股收益持平(甚至下降),那麼股東可能看不到太多好處。出於這個原因,你可以説,從長遠來看,每股收益比淨利潤更重要,假設目標是評估一家公司的股價是否可能增長。
我們對Pacific Radiance的利潤表現的看法
事實證明,Pacific Radiance無法將其利潤與現金流相匹配,其稀釋意味着每股收益增長落後於淨利潤增長。仔細想想,上述因素給我們的強烈印象是,根據法定利潤數字,太平洋輻射的潛在盈利能力並不像看起來那麼好。請記住,在分析一隻股票時,值得注意其中的風險。請注意,太平洋輻射正在顯現我們的投資分析中的3個警告信號其中兩個不應該被忽視。
在這篇文章中,我們研究了一些可能削弱利潤數字效用的因素,我們對此持謹慎態度。但還有很多其他方式可以讓你瞭解一家公司的看法。例如,許多人認為高股本回報率是有利的商業經濟指標,而另一些人則喜歡“跟着錢走”,尋找內部人士正在買入的股票。所以你可能想看看這個免費擁有高股本回報率的公司的集合,或內部人士正在購買的這份股票清單。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。